Cargando…

Retinal Endovascular Surgery with Tissue Plasminogen Activator Injection for Central Retinal Artery Occlusion

PURPOSE: To report 2 cases of central retinal artery occlusion (CRAO) who underwent retinal endovascular surgery with injection of tissue plasminogen activator (tPA) into the retinal artery and showed a remarkable improvement in visual acuity and retinal circulation. METHODS: Standard 25-G vitrectom...

Descripción completa

Detalles Bibliográficos
Autores principales: Takata, Yuta, Nitta, Yasuhito, Miyakoshi, Akio, Hayashi, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047559/
https://www.ncbi.nlm.nih.gov/pubmed/30022948
http://dx.doi.org/10.1159/000489696
_version_ 1783339962367737856
author Takata, Yuta
Nitta, Yasuhito
Miyakoshi, Akio
Hayashi, Atsushi
author_facet Takata, Yuta
Nitta, Yasuhito
Miyakoshi, Akio
Hayashi, Atsushi
author_sort Takata, Yuta
collection PubMed
description PURPOSE: To report 2 cases of central retinal artery occlusion (CRAO) who underwent retinal endovascular surgery with injection of tissue plasminogen activator (tPA) into the retinal artery and showed a remarkable improvement in visual acuity and retinal circulation. METHODS: Standard 25-G vitrectomy was performed under local anesthesia. Simultaneously, tPA (80,000 units/mL) solution was injected into the retinal artery of the optic disc for 2–3 min using a microneedle. Changes in visual acuity, fundus photography, optical coherence tomography (OCT), fluorescein angiography, and laser speckle flowgraphy (LSFG) results were examined. RESULTS: Both cases could be treated within 12 h after the onset of CRAO. Case 1 was a 47-year-old woman. Her visual acuity improved from counting fingers before operation to 0.08 logMAR 1 month after the surgery. However, thinning of the retina at the macula was observed by OCT. Case 2 was a 70-year-old man. His visual acuity improved from counting fingers to 0.1 logMAR 2 months after the surgery. Both fluorescein angiography and LSFG showed improvement in retinal circulation after the surgery in case 2. CONCLUSIONS: Retinal endovascular surgery with injection of tPA into the retinal artery was feasible and may be a way to improve visual acuity and retinal circulation when performed in the acute phase of CRAO.
format Online
Article
Text
id pubmed-6047559
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-60475592018-07-18 Retinal Endovascular Surgery with Tissue Plasminogen Activator Injection for Central Retinal Artery Occlusion Takata, Yuta Nitta, Yasuhito Miyakoshi, Akio Hayashi, Atsushi Case Rep Ophthalmol Case Report PURPOSE: To report 2 cases of central retinal artery occlusion (CRAO) who underwent retinal endovascular surgery with injection of tissue plasminogen activator (tPA) into the retinal artery and showed a remarkable improvement in visual acuity and retinal circulation. METHODS: Standard 25-G vitrectomy was performed under local anesthesia. Simultaneously, tPA (80,000 units/mL) solution was injected into the retinal artery of the optic disc for 2–3 min using a microneedle. Changes in visual acuity, fundus photography, optical coherence tomography (OCT), fluorescein angiography, and laser speckle flowgraphy (LSFG) results were examined. RESULTS: Both cases could be treated within 12 h after the onset of CRAO. Case 1 was a 47-year-old woman. Her visual acuity improved from counting fingers before operation to 0.08 logMAR 1 month after the surgery. However, thinning of the retina at the macula was observed by OCT. Case 2 was a 70-year-old man. His visual acuity improved from counting fingers to 0.1 logMAR 2 months after the surgery. Both fluorescein angiography and LSFG showed improvement in retinal circulation after the surgery in case 2. CONCLUSIONS: Retinal endovascular surgery with injection of tPA into the retinal artery was feasible and may be a way to improve visual acuity and retinal circulation when performed in the acute phase of CRAO. S. Karger AG 2018-06-22 /pmc/articles/PMC6047559/ /pubmed/30022948 http://dx.doi.org/10.1159/000489696 Text en Copyright © 2018 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Takata, Yuta
Nitta, Yasuhito
Miyakoshi, Akio
Hayashi, Atsushi
Retinal Endovascular Surgery with Tissue Plasminogen Activator Injection for Central Retinal Artery Occlusion
title Retinal Endovascular Surgery with Tissue Plasminogen Activator Injection for Central Retinal Artery Occlusion
title_full Retinal Endovascular Surgery with Tissue Plasminogen Activator Injection for Central Retinal Artery Occlusion
title_fullStr Retinal Endovascular Surgery with Tissue Plasminogen Activator Injection for Central Retinal Artery Occlusion
title_full_unstemmed Retinal Endovascular Surgery with Tissue Plasminogen Activator Injection for Central Retinal Artery Occlusion
title_short Retinal Endovascular Surgery with Tissue Plasminogen Activator Injection for Central Retinal Artery Occlusion
title_sort retinal endovascular surgery with tissue plasminogen activator injection for central retinal artery occlusion
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047559/
https://www.ncbi.nlm.nih.gov/pubmed/30022948
http://dx.doi.org/10.1159/000489696
work_keys_str_mv AT takatayuta retinalendovascularsurgerywithtissueplasminogenactivatorinjectionforcentralretinalarteryocclusion
AT nittayasuhito retinalendovascularsurgerywithtissueplasminogenactivatorinjectionforcentralretinalarteryocclusion
AT miyakoshiakio retinalendovascularsurgerywithtissueplasminogenactivatorinjectionforcentralretinalarteryocclusion
AT hayashiatsushi retinalendovascularsurgerywithtissueplasminogenactivatorinjectionforcentralretinalarteryocclusion